Marlow Hernandez, the founder and former CEO of Cano Health, was set to face a trial over allegations that he fraudulently ...

Tens of thousands of Kaiser Permanente workers in California and Hawaii have gone on strike, demanding safer staffing levels ...

CMS Administrator Dr. Mehmet Oz said that Medicaid’s rapid spending growth is unsustainable and criticized state financing ...

Insurers are cutting coverage for costly GLP-1 weight loss drugs, sparking backlash from advocates who say they're vital for ...

Experts warn that the Trump administration’s new $100,000 fee for H-1B visa applications could worsen healthcare’s workforce ...

Novo Nordisk is acquiring Akero Therapeutics for drug candidate efruxifermin, which executive say could be first and best in ...

Seven months ago, independent clinical trial observers peeked at interim data for Praxis Precision Medicines’ essential tremor drug and recommended stopping the Phase 3 studies. Praxis kept going. On ...

Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.

WellTheory, a digital health company for autoimmune disease, announced on Tuesday that it has raised $14 million in Series A funding, which will help the company scale and advance its AI. Atherton, ...

From left to right: Moderator Michael Kalishman, chief venture officer, Sentara Health; Nick Culbertson, managing director, Techstars; Dr. Ngoc-Anh Nguyen, vice chair of research, Houston Methodist ...